| ★ |  Sotatercept May Improve Right Heart Function in #pulmonaryhypertension | | 232 | Estados Unidos | |
| 8 |  Idiopathic Pulmonary Fibrosis - Treatment and New Hope | MedCram - Medical Lectures Explained CLEARLY @medcram | 9.0K | Estados Unidos | 85 |
| 15 |  L’étude SCOUT HCM Un traitement par inhibiteur de la myosine cardiaque améliore l'obstruction chez | Cardio-online @cardio-online9873 | 2.8K | Francia | 85 |
| 2 |  Étude CADENCE : Résultats prometteurs pour le sotatercept dans une forme rare d'HTAP | Cardio-online @cardio-online9873 | 2.3K | Francia | 89 |
| 13 |  #Hypertension Awareness & Treatment to Reduce #cardiovascular Disease | | 649 | Estados Unidos | 85 |
| 9 |  Efdoralprin Alfa Normalizes Alpha-1 Antitrypsin Levels I #ats2026 | | 548 | Estados Unidos | 85 |
| 20 |  What Heart Rate and 6-Minute Walk Test Reveal About #COPD Exacerbation Risk | | 548 | Estados Unidos | 84 |
| 10 |  Inhaled Treprostinil for IPF: TETON-1 Phase 3 Results With Steven Nathan, MD | ATS 2026 | | 301 | Estados Unidos | 85 |
| 11 |  Ralinepag Cuts PAH Clinical Worsening Risk by 55%, With Vallerie McLaughlin, MD | ATS 2026 | | 290 | Estados Unidos | 85 |
| 6 |  Avances terapéuticos en Hipertensión Pulmonar y su impacto en pacientes con comorbilidades | | 209 | Argentina | 86 |
| 17 |  Mixed AERIFY Data May Delay Itepekimab Approval Pathway in COPD, With Klaus F. Rabe, MD, PhD | | 198 | Estados Unidos | 84 |
| 18 |  Insuficiencia Cardiaca con fe preservada y la realidad argentina: ¿Dónde estamos hoy? | | 152 | Argentina | 84 |
| 1 |  Sotatercept May Improve RV Function in Group 3 3 Pulmonary Hypertension | | 112 | Estados Unidos | 96 |
| 19 |  PFA for PAF +/- LAAC | Jay Sengupta, MD, FACC, FHRS | Minneapolis Heart Institute Foundation @mplsheartinstfound | 112 | Estados Unidos | 84 |
| 5 |  Rethinking Advanced Heart Failure: Treat the Disease, Not the Symptoms | | 110 | Estados Unidos | 86 |
| 4 |  AERIFY: Phase 3 Data Reveal Challenges, Potential of Itepekimab in COPD | | 105 | Estados Unidos | 86 |
| 7 |  Hipertensión pulmonar en Puerto Rico : Diagnóstico tardío y factores de riesgo | | 69 | Puerto Rico | 86 |
| 14 |  Improving Heart Failure Care for All, With Joshua Remick, MD | | 59 | Estados Unidos | 85 |
| 12 |  ATS 2026 Pulmonology: AD109, Ralinepag, ALIS, Itepekimab & More | HCPLive Expert Interviews | | 55 | Estados Unidos | 85 |
| 16 |  Screening and treatment of systemic sclerosis-associated PAH: where do we stand in 2024? | | 53 | — | 85 |
| 3 |  SGLT2 Inhibitors May Reduce COPD Readmissions I ATS 2026 | | 48 | Estados Unidos | 87 |